A prospective study to evaluate the intra-individual reproducibility of bone scans for quantitative assessment in patients with metastatic prostate cancer

BACKGROUND: The Bone Scan Index (BSI) is used to quantitatively assess the total tumour burden in bone scans of patients with metastatic prostate cancer. The clinical utility of BSI has recently been validated as a prognostic imaging biomarker. However, the clinical utility of the on-treatment chang...

Descripción completa

Detalles Bibliográficos
Autores principales: Reza, Mariana, Kaboteh, Reza, Sadik, May, Bjartell, Anders, Wollmer, Per, Trägårdh, Elin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5935944/
https://www.ncbi.nlm.nih.gov/pubmed/29728144
http://dx.doi.org/10.1186/s12880-018-0257-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5935944/
https://www.ncbi.nlm.nih.gov/pubmed/29728144
http://dx.doi.org/10.1186/s12880-018-0257-5

Ejemplares similares